Xencor, Inc.
NASDAQ:XNCRBiotechnology
-$0.13 today
- Market cap
- $2.58B
- Beta
- 0.93
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$2.29
Volume 0.87M
Average 0.80M
XNCR Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Xencor, Inc.NASDAQ: XNCR
Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares (diluted) grows, but more slowly than its trailing trend
Q2 FY2026 weighted avg shares (diluted) of 75.86M shares rose 2.1% year over year, behind the +5.1% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at +7.6% a year.
Context
- Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +2.1% toward the trailing-twelve-month pace of +5.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 74.24M USD
- Year-over-year change
- +14.1%
- 4-year CAGR
- +5.3%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 74.24M | +14.1% |
| FY2024 | 2024-12-31 | 65.04M | +7.5% |
| FY2023 | 2023-12-31 | 60.5M | +1.4% |
| FY2022 | 2022-12-31 | 59.65M | -1.4% |
| FY2021 | 2021-12-31 | 60.5M | — |
Weighted Avg Shares (Diluted) vs competitors
How XNCR compares with its peers on the latest reported figures
- XNCR's LTM Jun 2026 weighted avg shares (diluted) of 74.94M shares is the 6th highest of the 11 companies compared; the peer median is 80.89M shares.
- Its year-over-year change of +5.1% is the 6th highest of 9, against a peer median of +9.7%.
- Over three fiscal years its annual growth of +7.6% compares with a peer median of +3.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | 637.25M | — | -1.7% | |
| FY2025 | 145.58M | +21.2% | +19.1% | |
| LTM Aug 2026 | 108.1M | +31.0% | +21.3% | |
| LTM Mar 2026 | 94.08M | +4.2% | +2.7% | |
| FY2025 | 89.42M | +10.3% | +3.9% | |
| LTM Jun 2026 | 74.94M | +5.1% | +7.6% | |
| LTM Sep 2026 | 72.36M | +9.0% | +12.4% | |
| LTM Mar 2026 | 63.26M | +0.8% | +0.9% | |
| LTM Mar 2026 | 50.99M | -0.4% | +3.3% | |
| LTM Jun 2024 | 35.23M | — | +2.9% | |
| LTM Jun 2026 | 23.04M | +63.6% | +10.6% | |
| Peer median (excluding XNCR) | 80.89M | +9.7% | +3.6% | |
Competitors are the stored peer set for XNCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 275.11M | 164.58M | 174.62M | 110.49M | 125.58M |
| Cost of Revenue | 192.51M | 199.56M | 0 | 227.69M | 10.51M |
| Gross Profit | 82.6M | (34.98M) | 174.62M | (117.19M) | 115.06M |
| Gross Margin | 30.0% | -21.3% | 100.0% | -106.1% | 91.6% |
| Research & Development | 192.51M | 199.56M | 253.6M | 227.69M | 239.43M |
| Selling, General & Admin | 38.84M | 47.49M | 53.38M | 58.89M | 63.64M |
| Operating Expenses | 38.84M | 47.49M | 306.98M | 61.22M | 292.57M |
| Depreciation & Amortization | 7.49M | 8.8M | 11.5M | 12.11M | 10.51M |
| EBITDA | 90.14M | (45.7M) | (101.96M) | (186.17M) | (46.98M) |
| EBITDA Margin | 32.8% | -27.8% | -58.4% | -168.5% | -37.4% |
| Operating Income | 43.77M | (82.47M) | (132.36M) | (178.41M) | (177.5M) |
| Operating Margin | 15.9% | -50.1% | -75.8% | -161.5% | -141.4% |
| Interest Income | 862K | 4.82M | 18.63M | 31.93M | 27.52M |
| Interest Expense | 13K | 0 | 0 | 36.64M | 31.93M |
| Other Income / Expenses | 38.86M | 27.97M | 12.73M | (56.52M) | 87.87M |
| Income Before Tax | 82.63M | (54.51M) | (119.63M) | (234.92M) | (89.42M) |
| Pre-Tax Margin | 30.0% | -33.1% | -68.5% | -212.6% | -71.2% |
| Income Tax Expense | 0 | 673K | 13.66M | 1.62M | 2.5M |
| Net Income | 82.63M | (55.18M) | (133.13M) | (232.62M) | (91.92M) |
| Net Margin | 30.0% | -33.5% | -76.2% | -210.5% | -73.2% |
| EPS (Basic) | 1.42 | (0.93) | (2.08) | (3.58) | (1.24) |
| EPS (Diluted) | 1.37 | (0.93) | (2.08) | (3.58) | (1.24) |
| Weighted Avg Shares | 58.38M | 59.65M | 60.5M | 65.04M | 74.24M |
| Weighted Avg Shares (Diluted) | 60.5M | 59.65M | 60.5M | 65.04M | 74.24M |
Xencor, Inc.
NASDAQ:XNCR
Intrinsic Alpha fair value
Locked
Current Price
$34.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.